Revelation Biosciences, Inc. (REVB) stock
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
$4.26−0.12 (-2.63%)
Close on Nov 13, 2026Market cap $2.91MP/E –Yield –
Revelation Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Revelation Biosciences's enterprise value was $5.56M on Nov 11, 2026, against $83.14M a year earlier. Over the last 5 years it ranged from -$8.91M to $102.71B, with a median of $3.36B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.56M | -91.8% |
| 2025 | Dec 31, 2025 | $67.60M | -97.5% |
| 2024 | Dec 31, 2024 | $2.65B | -84.3% |
| 2023 | Dec 29, 2023 | $16.94B | -31.6% |
| 2022 | Dec 30, 2022 | $24.76B | -75.9% |
| 2021 | Dec 31, 2021 | $102.71B | -14.4% |
| 2020 | Dec 31, 2020 | $119.94B | – |
See a number that looks wrong?